Skip to main content
. 2022 Apr 7;14(4):814. doi: 10.3390/pharmaceutics14040814

Figure 2.

Figure 2

(a) Schematic representation of CuPRiXX with a detailed structure of DOTAGA(Gd) and uncomplexed DOTAGA groups; (b) HPLC-UV chromatograms of CuPRiX1 and CuPRiX2 (10 µL, 100 g/L) recorded at 295 nm; (c) Hydrodynamic diameter distribution in volume obtained by dynamic light scattering; (d) Zeta potential vs. pH for CuPRiX1 and CuPRiX2; (e) Comparison of the amount of DOTA groups between CuPRiX1 and CuPRiX2 based on their unchelated DOTAGA measurements.